Severe Acute Respiratory Syndrome M (CT) Blocking Peptide

Severe Acute Respiratory Syndrome M (CT) Blocking Peptide

Product No.: S547

[product_table name="All Top" skus="S547"]

- -
- -
Target
SARS M
Product Type
Blocking Peptide

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Virus
Product Concentration
0.2 mg/ml
Amino Acid Location
13 Amino acids near the C-terminus of SARS M protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
13 amino acids near the carboxy terminus of SARS M protein.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background
Severe Acute Respiratory Syndrome Membrane Protein peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

References & Citations

1. Shamji AF, Ngheim P, and Schreiber SL. Integration of growth factor and nutrient signaling: implications for cancer biology. Mol. Cell 2003; 12:271-80. 2. Fingar DC and Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004; 23:3151-71. 3. Yonezawa K, Tokunaga C, Oshiro N, et al. Raptor, a binding partner of target of rapamycin. Biochem. Biophys. Res. Commun. 2004; 313:437-441. 4. Hara K, Yonezawa K, Weng QP, et al. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 1998; 273:14484-94.
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.